• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哪种淋巴结分期系统能更好地预测胃癌患者的预后?在西方三级中心,对 3 种不同的胃癌淋巴结分类方法进行比较研究。

Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.

机构信息

Complutense University of Madrid.

Departments of Pathology.

出版信息

Am J Clin Oncol. 2021 Jan 1;44(1):1-9. doi: 10.1097/COC.0000000000000770.

DOI:10.1097/COC.0000000000000770
PMID:33086233
Abstract

INTRODUCTION

Gastric cancer (GC) is an aggressive disease with high mortality rates. Lymph node (LN) staging of GC is a major source of controversy. The aim of this study is to compare the prognostic value of 3 different LN classifications for patients with resected GC: the eighth TNM staging system, lymph node ratio (LNR, ratio between positive and total LN) and a new anatomic-based classification (Choi classification).

MATERIALS AND METHODS

A retrospective study of all cases of GC resected in a tertiary hospital in Spain (n=377). Clinical data were collected; histologic slides were reviewed; and univariate and multivariate analyses of disease-free survival (DFS) and overall survival (OS) were performed.

RESULTS

In all, 315 patients fulfilled inclusion criteria. Univariate analysis showed that all classifications were significantly associated with tumor death and progression (P<0.001). All staging systems were independent prognostic factors for DFS. Area under the curve ratios for Choi, N stage, and LNR classifications were 0.738, 0.730, and 0.735, respectively. TNM and LNR classifications were independent prognosticators for OS, while Choi classification was an independent factor only in patients with ≥16 LN resected. Area under the curve ratios for Choi, N stage, and LNR classifications were 0.707, 0.728, and 0.732, respectively. Kaplan-Meier curves depending on LNR classification showed the best patient stratification for both OS and DFS.

CONCLUSIONS

The 3-staging systems had similar prognostic performance, but LNR-based classification stratified patients better. Further studies are needed to evaluate the impact of the number of LN examined, cutoff values, and anatomic extent of LN disease in GC.

摘要

简介

胃癌(GC)是一种死亡率很高的侵袭性疾病。GC 的淋巴结(LN)分期是一个主要的争议来源。本研究的目的是比较 3 种不同 LN 分类对接受 GC 切除的患者的预后价值:第八版 TNM 分期系统、淋巴结比率(LN 比,阳性和总 LN 之间的比值)和新的基于解剖的分类(Choi 分类)。

材料和方法

对西班牙一家三级医院接受 GC 切除的所有病例进行回顾性研究(n=377)。收集临床数据;复查组织切片;并对无病生存率(DFS)和总生存率(OS)进行单因素和多因素分析。

结果

共有 315 例患者符合纳入标准。单因素分析显示,所有分类均与肿瘤死亡和进展显著相关(P<0.001)。所有分期系统均为 DFS 的独立预后因素。Choi、N 分期和 LNR 分类的曲线下面积比分别为 0.738、0.730 和 0.735。TNM 和 LNR 分类是 OS 的独立预后因素,而 Choi 分类仅在切除≥16 个 LN 的患者中是独立因素。Choi、N 分期和 LNR 分类的曲线下面积比分别为 0.707、0.728 和 0.732。根据 LNR 分类绘制的 Kaplan-Meier 曲线在 OS 和 DFS 方面对患者的分层最佳。

结论

这 3 种分期系统具有相似的预后性能,但基于 LN 比的分类对患者的分层更好。需要进一步研究以评估检查的 LN 数量、截断值和 GC 中 LN 疾病的解剖范围对预后的影响。

相似文献

1
Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.哪种淋巴结分期系统能更好地预测胃癌患者的预后?在西方三级中心,对 3 种不同的胃癌淋巴结分类方法进行比较研究。
Am J Clin Oncol. 2021 Jan 1;44(1):1-9. doi: 10.1097/COC.0000000000000770.
2
Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer.朝着淋巴结比率分类标准化迈进:验证和比较不同的淋巴结比率分类,以预测可切除胃癌患者的预后。
Ann Diagn Pathol. 2021 Jun;52:151738. doi: 10.1016/j.anndiagpath.2021.151738. Epub 2021 Mar 31.
3
Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.为接受胃癌切除术的患者开发简化的肿瘤-淋巴结比率分类系统:一项西方研究。
Ann Diagn Pathol. 2021 Feb;50:151677. doi: 10.1016/j.anndiagpath.2020.151677. Epub 2020 Dec 7.
4
The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.不同淋巴结分期系统对胃腺癌手术后淋巴结≤15枚患者的预后价值。
Acta Chir Belg. 2018 Feb;118(1):1-6. doi: 10.1080/00015458.2017.1346036. Epub 2017 Jul 3.
5
Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy.三种不同淋巴结分期系统对胃癌患者D2淋巴结清扫术后生存的预后价值
Tumour Biol. 2016 Aug;37(8):11105-13. doi: 10.1007/s13277-015-4191-7. Epub 2016 Feb 24.
6
Lymph node ratio-based staging system for esophageal squamous cell carcinoma.基于淋巴结比率的食管鳞状细胞癌分期系统
World J Gastroenterol. 2015 Jun 28;21(24):7514-21. doi: 10.3748/wjg.v21.i24.7514.
7
Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China.胃癌手术后淋巴结阳性对数优势(LODDS)对预后预测的优越性:中国 7620 例患者的多机构分析。
Surg Today. 2021 Jan;51(1):101-110. doi: 10.1007/s00595-020-02091-7. Epub 2020 Aug 4.
8
The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.基于淋巴结评估 N3b 期胃癌患者的最佳检查淋巴结数量和预测生存结局的预后模型。
Asia Pac J Clin Oncol. 2021 Apr;17(2):e117-e124. doi: 10.1111/ajco.13358. Epub 2020 Aug 6.
9
[Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].[根治性切除术后食管胃交界腺癌患者转移淋巴结数量及转移淋巴结比率对预后的影响]
Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):141-6.
10
Prognostic value of a modified pathological staging system for gastric cancer based on the number of retrieved lymph nodes and metastatic lymph node ratio.基于淋巴结检出数和转移淋巴结比例的改良胃癌病理分期系统的预后价值。
PeerJ. 2024 Oct 1;12:e18165. doi: 10.7717/peerj.18165. eCollection 2024.

引用本文的文献

1
Clinical study on the safety, efficacy, and prognosis of molecular targeted drug therapy for advanced gastric cancer.晚期胃癌分子靶向药物治疗的安全性、有效性及预后的临床研究
Am J Transl Res. 2021 May 15;13(5):4704-4711. eCollection 2021.